Secondary Hyperaldosteronism Documentation Best Practices
Customize your policy alerts
Sign up for all wellsense_health_plan policy alerts
Know when wellsense_health_plan releases new policies or updates existing guidance.
Monitor payer policy activity
Guidance for clinicians on documenting secondary hyperaldosteronism (ICD-10: E26.1) to ensure accurate diagnosis capture and linkage to the primary causal condition for WellSense Health Plan members.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.